Positive Mindfulness Program and Wellbeing in Chronic Pain
Launched by CANTERBURY CHRIST CHURCH UNIVERSITY · Mar 2, 2017
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
Practicing mindfulness has been demonstrated to have a variety of benefits such as reducing stress, depression, anxiety, insomnia and pain symptoms. Positive psychology interventions have been shown to increase well-being by enhancing resilience, improving health and having a positive impact on levels of anxiety and depression.
The clinical guidance for treating individuals with chronic pain recommends reducing stress and improving sleep and supporting patients to gain a greater sense of control over their illness. Mindfulness has been shown to be effective in supporting patients with chro...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Is experiencing chronic pain that has lasted for at least 3 months at time of entry to study
- • Has access to the internet daily
- Exclusion Criteria:
- • Currently receiving another form of psychological intervention
- • Post Traumatic Stress Disorder
- • Eating disorders
- • Substance abuse (inc prescription drugs)
- • Subjected to torture or abuse Suspected factitious illness or dissociative symptoms
About Canterbury Christ Church University
Canterbury Christ Church University is a leading higher education institution in the UK, renowned for its commitment to research excellence and community engagement. With a strong focus on health and social care, the university undertakes a range of clinical trials aimed at advancing medical knowledge and improving patient outcomes. By leveraging interdisciplinary collaboration and state-of-the-art facilities, Canterbury Christ Church University strives to contribute valuable insights to the scientific community while fostering innovation in healthcare practices. Its dedicated team of researchers and practitioners work diligently to ensure the highest standards of ethical conduct and scientific rigor in all clinical studies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oxford, Oxfordshire, United Kingdom
Tunbridge Wells, Kent, United Kingdom
London, , United Kingdom
Patients applied
Trial Officials
Tony Lavender, Professor
Study Director
Canterbury Christ Church University
Itai Ivtzan, Dr
Principal Investigator
University of East London
Abi Davison Jenkins, DClinPsy
Principal Investigator
Canterbury Christ Church University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials